Filing status
- Accounts due
- 27 October 2027
- Last accounts
- 31 January 2026
- Conf. stmt due
- 16 January 2027
- Last conf. stmt
- 2 January 2026
Trinity Life Sciences UK Limited
- Incorporated
- 2 January 2015 (11 years)
- Previously known as
- Exeter Pharma Consultancy, Ltd. (until 2 April 2024)
- Industry
- Management consultancy activities other than financial management (70229)
- Directors
- Paul Rader LuccheseRebecca Mcnamara
- Accounts type
- Small
- Region
- Greater London
- Address
- Lower Third Floor Evelyn SuiteQuantum House22-24 Red Lion CourtLondonEC4A 3EB
Officers 3 active
Officer details are public data from the Companies House register.
Lucchese, Paul Rader
Director · Appointed 11 March 2026
American
Born July 1966 (60)
Mcnamara, Rebecca
Director · Appointed 14 February 2024
American
Born September 1973 (53)
Martin De Bustamante, Monica Ann
Secretary · Appointed 12 January 2016
Officer history (4 former)
11 March 2026
Appointed Lucchese, Paul Rader as Director
2 February 2026
Resigned Sandberg Orne, Leslie as Director
2 February 2026
Resigned Martin De Bustamante, Monica Ann as Director
14 February 2024
Appointed Mcnamara, Rebecca as Director
14 February 2024
Appointed Sandberg Orne, Leslie as Director
11 July 2021
Resigned Chowdhury, Cyrus Azhar as Director
12 January 2016
Appointed Martin De Bustamante, Monica Ann as Secretary
12 January 2016
2 January 2015
2 January 2015
Appointed Chowdhury, Cyrus Azhar as Director
2 January 2015
Appointed Martin De Bustamante, Monica Ann as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (1)
14 January 2024
Ceased Exeter Pharma Consultancy, LLC — Owns 75–100% of shares
Financials
Figures from 2025 accounts. Newer accounts, made up to 31 January 2026, are filed but not read yet. See them on Companies House
- Net Assets
- (£81,213)
- Cash
- £318,264
- Employees
- 40
- Debt Ratio
- 102%
- Current Ratio
- 0.5x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £1,764,732 | £356,971 | £21,121 | £8,951 | £14,948 | £21,566 |
| Current Assets | £1,662,244 | £1,194,782 | £1,700,614 | £539,526 | £496,409 | £344,877 |
| Debtors | £1,343,980 | £420,633 | £1,285,918 | £338,518 | £449,743 | £301,603 |
| Cash | £318,264 | £774,149 | £414,696 | £201,008 | £46,666 | £43,274 |
| Creditors (< 1 year) | £3,447,290 | £1,965,232 | £2,532,129 | £1,012,835 | £498,487 | £284,401 |
| Net Current Assets | (£1,785,046) | (£770,450) | (£831,515) | (£473,309) | (£2,078) | £60,476 |
| Net Assets | (£81,213) | (£447,294) | (£814,407) | (£466,059) | £10,030 | £77,945 |
| Shareholder Funds | (£81,213) | (£447,294) | (£814,407) | (£466,059) | £10,030 | £77,945 |
Filings 41
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 October 2026 | Accounts for a small company | 31 January 2026 | ||
| 15 September 2026 | Termination of appointment of a director | |||
| 14 September 2026 | Termination of appointment of a director | |||
| 14 September 2026 | Appointment of a director | |||
| 21 March 2026 | Confirmation statement with updates | 2 January 2026 |
Some other companies at this address
Other companies in this industry
Leicester
London
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →